These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 294132

  • 1. Connective tissue changes in systemic sclerosis and the use of D-penicillamine.
    Jayson MI.
    Agents Actions Suppl; 1979; (5):149-57. PubMed ID: 294132
    [No Abstract] [Full Text] [Related]

  • 2. Progressive systemic sclerosis and penicillamine.
    Rodnan GP.
    J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [D-Penicillamine effect on collagen synthesis and structural maintenance Red Sirius staining with polarized-light examination. The value of this staining in cases of collagen diseases (author's transl)].
    Pieraggi MT, Bonafe JL.
    Ann Pathol; 1982; 2(2):155-7. PubMed ID: 6179525
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)].
    Böni A, Pavelka K, Kludas M.
    Munch Med Wochenschr; 1969 Aug 01; 111(31):1580-4. PubMed ID: 5394493
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of generalized scleroderma with inhibitors of connective tissue formation.
    Asboe-Hansen G.
    Acta Derm Venereol; 1975 Aug 01; 55(6):461-5. PubMed ID: 55038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Systemic sclerosis].
    Gustafsson R.
    Nord Med; 1994 Aug 01; 109(8-9):236-7. PubMed ID: 7937033
    [Abstract] [Full Text] [Related]

  • 11. [Ultrastructural comparative study of the behavior of collagen tissue and elastic tissue during 3 pathological states (Marfans disease, scleroderma due to vitamin K-1 lathyrogenic effect of penicillamine)].
    Gauthier Y, Surlève-Bazeille JE, Gauthier O, Texier L.
    Ann Dermatol Syphiligr (Paris); 1973 Aug 01; 100(5-6):525-9. PubMed ID: 4802994
    [No Abstract] [Full Text] [Related]

  • 12. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
    Katayama Y, Kohriyama K, Matsui T.
    J Rheumatol; 1999 Nov 01; 26(11):2493-5. PubMed ID: 10555917
    [Abstract] [Full Text] [Related]

  • 13. [Penicillamine in the treatment of scleroderma. Lathyrogenic drugs].
    Szczepanski A.
    Przegl Dermatol; 1971 Nov 01; 58(3):355-9. PubMed ID: 4944035
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Penicillamine for systemic sclerosis?
    Drug Ther Bull; 1974 Sep 13; 12(19):75-6. PubMed ID: 4469492
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Scleroderma (progressive systemic sclerosis, PSS); pathophysiological, clinical and pharmacological aspects of the syndrome.
    Herbai G.
    Acta Med Acad Sci Hung; 1978 Sep 13; 35(3-4):201-11. PubMed ID: 756110
    [Abstract] [Full Text] [Related]

  • 18. [D-penicillamine in the treatment of progressive systemic sclerosis].
    Marques Neto JF, Manzato LC, Samara AM.
    AMB Rev Assoc Med Bras; 1980 Jun 13; 26(6):191-3. PubMed ID: 6970374
    [No Abstract] [Full Text] [Related]

  • 19. Penicillamine types in the sclerodermas.
    Tio TH.
    Proc R Soc Med; 1977 Jun 13; 70 Suppl 3(Suppl 3):78-9. PubMed ID: 122680
    [No Abstract] [Full Text] [Related]

  • 20. [Pathophysiology of fibroses. Progressive systemic scleroderma as a model disease].
    Hein R, Mauch C, Braun-Falco O, Krieg T.
    Hautarzt; 1988 Feb 13; 39(2):65-71. PubMed ID: 3283077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.